Serotonergic Neuronal Sprouting as a Potential Mechanism of Recovery in Multiple Sclerosis

References

• Anderscn O., Johansson B. B., Svennerholm L. Monoamine metabolites in successive samples of spinal fluid: a comparison between healthy volunteers and patients with multiple sclerosis. Acta Neurologica Scandinavica 1981; 63: 247–254
   PubMedGoogle Scholar
• Anderson E. G., Proudfit H. K. The functional role of the bulbospinal serotonergic nervous system. Serotonin: neurotransmission and behavior, B. L. Jacobs, A. Gelperin. MIT Press, London 1981; 307–138
   Google Scholar
• Azmita E. C., Whilaker-Azmitia P. M. Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. Journal of Clinical Psychiatry 1991; 52: 4–16
   Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsyciatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Bieger D., White S. R. Anatomical evidenee for bulbospinal monoamine axon damage in rats with experimental allergic encephalomyelitis. Neuroscienee 1981; 6: 1745–1752
   PubMedGoogle Scholar
• Bjorklund A., Katzman R., Stenevi V., West K. A. Development and growth of axonal sprouts from noradrenaline and 5-hydroxytryptamine neurons in the rat spinal cod. Bruin Research 1971; 31: 21–33
   PubMedGoogle Scholar
• Carlsson M., Carlsson A. In vivp evidence for a grealer brain tryptophan hydroxylasc capacity in female than male rats. Naunyn Schmiedebergs Archives of Pharmacology 1988; 338: 345–349
   PubMedGoogle Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Aminc metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Dong Y. Q. The therapeutic effect of pulsed electric field on experimental spinal cord injury. Chung Hua Wai Ko Tsa Chih (China) 1997; 30: 180–183
   Google Scholar
• Feurer C., Prentice D. E., Cammisuli S. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Journal of Immunology 1985; 10: 159–166
   Google Scholar
• Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994; 343: 271–275
   PubMed Web of Science ®Google Scholar
• Georgi W. Multiple sclerose: pathologische - anatomische befunde multiple sclerose bei klinisch nicht diagnostizierten krankheiten. Schweizerischer Medizinische Wochensehrift 1961; 91: 605–607
   PubMedGoogle Scholar
• Ghatak N. R., Hirano A., Lijtmaer H., Zimmerman H. M. Asymptomatic demyelinated plaque in the spinal cord. Archives of Neurology 1974; 30: 484–486
   PubMedGoogle Scholar
• Gilbert J. J., Sadler M. Unsuspected multiple sclerosis. Archives of Neurology 1983; 40: 533–536
   PubMedGoogle Scholar
• Haring J. H. Reorganization of the area dentata serotoneregc plexus after lesion of the median raphe nucleus. Journal of Comparative Neurology 1991; 306: 576–584
   PubMed Web of Science ®Google Scholar
• Hashimoto T., Fukuda N. Contribution of serotonin neurons to the functional recovery after spinal cord injury in rats. Brain Research 1991; 539: 263–270
   PubMedGoogle Scholar
• Hyyppa M. T., Jolma T., Riekkinen P. B., Rinne U. K. Effects of L-tryptophan on central indoleamine metabolism and short-lading neurologic disrurbances in multiple sclerosis. Journal of Transmission 1975; 37: 297–304
   PubMed Web of Science ®Google Scholar
• Jacobs L., Kinkel P. R., Kinkel W. R. Silent brain lesions in patients with isolated optic neuritis. Archives of Neurology 1986; 43: 452–455
   PubMedGoogle Scholar
• Johansson B., Roos B. E. 5-hydroxyindoleacetic acid and homovanillic acid in CSF of patients with neurological disease. European Neurology 1977; 11: 37–45
   Web of Science ®Google Scholar
• Johnson K. P. Experimental therapy of relapsing-remitting multiple sclerosis with copolymer-1. Annals of Neurology 1994; 36: S115–S117, (suppl)
   PubMed Web of Science ®Google Scholar
• Koya G., Suzuki M., Baba M., Iwabuchi T. An autopsy case of concurrence of multiple sclerosis and glioma. Hirosaki Medical Journal 1977; 29: 588–596
   Google Scholar
• Krenger W., Honegger C. G., Feurer C., Cammisuli S. Changes in neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rats brain and spinal cord. Journal of Neurochemistry 1986; 47: 1241–1254
   Google Scholar
• Lassman H., Wisniewski H. M. Chronic relasping EAE: time course of neurological symptoms and pathology. Acta Neuropathologica (Berlin) 1978; 43: 35–42
   PubMedGoogle Scholar
• Lassman H., Kitz K., Wisniewski H. M. Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis. Acta Neuropathologica (Berlin) 1980; 51: 191–201
   PubMedGoogle Scholar
• Lombardi G., Gandolfi O., Dall'Olio R., Pellegrini-Giampietro D. E., Beni M., Carla V., Consolazione A., Moroni F. Lesioning and recovery of the serotonergic projections to the hippocampus. Brain Research 1987; 41: 275–281
   Google Scholar
• Lycke E., Roos B. E. Brain monoamines in guinea-pigs with experimental allergic encephalomyelitis. International Archives of Allergy and Applied Immunology 1973; 45: 341–351
   PubMedGoogle Scholar
• Mack Kay R. P., Hirano A. Forms of benign multiple sclerosis: report of two clinically silent cases discovered at autopsy. Archives of Neurology 1967; 17: 588–600
   PubMedGoogle Scholar
• Mamounas L. A., Wilson M. A., Axt K. J., Molliver M. E. Morphological aspects of serotonergic innervation. Advances in neurosciences: serotonin. CNS receptors and brain functions, P. B. Bradley, S. L. Handley, S. J. Cooper, B. J. Key, N. M. Barnes, J. H. Coote. Pergamon Press., Oxford 1992; Vol. 85: 97–118
   Google Scholar
• Morariu M., Klutzow W. F. Subclinical multiple sclerosis. Journal of Neurology 1976; 213: 71–76
   PubMed Web of Science ®Google Scholar
• Namerow N. S., Thompson L. B. Plaques, symptoms, and the remitting course of multiple sclerosis. Neurology 1969; 19: 765–774
   PubMedGoogle Scholar
• Nieuwenhuys R. Chemoarchitecture of the brain. Springer-Verlag., Berlin 1985; 33–41
   Google Scholar
• Orgel M. G., O'Brien W. J., Murray H. M. Pulsing electromagnetic field therapy in nerve regeneration: an experimental study in the cat. Plastic Reconstruction Surgery 1984; 73: 173–183
   PubMed Web of Science ®Google Scholar
• Phadke J. G., Best P. V. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 414–420
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis, observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Raine C. S. Neuropathology. Neurobehavioral aspects of multiple sclerosis, S. M. Rao. Oxford University Press., New York 1990; 15–36
   Google Scholar
• Russel D. S. Trauma and multiple sclerosis. Lancet 1964; 1: 978
   Google Scholar
• Samathanam G. K., White S. R., Kalivas P. W., Duffy P. Effects of 5-hydr- oxytryptophan on extracellular serotonin in the spinal cord of rats with experimental allergic encephalomyelitis. Brain Research 1991; 559: 37–43
   PubMedGoogle Scholar
• Sandyk R. Therapeutic effects of AC pulsed electromagnetic fields in multiple sclerosis. Journal of Alternative and Complementary Medicine 1997; 3: 365–386
   PubMedGoogle Scholar
• Sarhan H., Fillion G. The therapeutic potential of 5-HT1B autoreceptors and heteroreceptors and 5-HT-moduline in CNS disorders. CNS Spectrums 1998; 3: 50–58
   Google Scholar
• Saruhashi Y., Young W., Perkins R. The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Experimental Neurology 1996; 139: 203–213
   PubMed Web of Science ®Google Scholar
• Scott C. F., Cashman N., Spitler L. E. Experimental allergic encephalitis: treatment with drugs which alter CNS serotonin levels. Journal of Immunopharmacology 1982–1983; 4: 153–162
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Tai Q., Palazzolo K. L., Goshgarian H. G. Synaptic plasticity of 5-hydrouytrypta-mine-immunoreactive terminals in the phrenic nucleus following spinal cod injury: a quantitative electron microscopic analysis. Journal of Comparative Neurology 1997; 386: 613–624
   PubMedGoogle Scholar
• Trooster W. J., Teelken A. W., Gerrils P. O., Lijnema T. H., Loof J. G., Minderhoud J. M., Nieuwenhuis P. The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis. Clinical Neurology and Neurosurgery 1996; 98: 222–226
   PubMedGoogle Scholar
• Van Luijtelaar M. G. P. A., Steinbusch H. W. M., Tonnaer A. A. D. M. Similarities between aberrant serotonergic fibers in the aged and 5.7-DHT denerated young adult rat brain. Experimental Brain Research 1980; 78: 81–89
   Google Scholar
• Vuia O. The benign form of multiple sclerosis: anatomo-clinical aspects. Aeta Neurologica Scandinavica 1977; 55: 289–393
   PubMed Web of Science ®Google Scholar
• Vuia D., Bieger D., White S. R. Intraspinal nerve terminals immuno-reactive for tyrosine hydroxylase. serotonin and substance P in guinea-pigs with acute experimental allergic encephalomyelitis. Neuroscience 1988; 26: 253–259
   PubMedGoogle Scholar
• Failure of 5-hydroxytryptophan to increase lumbar MSR amplitude in rats paralyzed with experimental allergic encephalomyelitis. Brain Research 1979; 177: 157–163
   PubMedGoogle Scholar
• White S. R., Rieger D. Central serotonin receptor sensitivity in rats with experimental allergic encephalomyelitis. Research Communications in Chemical Pathology and Pharmacology 1980; 30: 269–281
   PubMedGoogle Scholar
• White S. R., Bowker R. M. Retrograde transport of hoseradish peroxidase is specifically impaired in bulbospinal serotonin axons during experimental allergic encephalomyelitis. Journal of Neuroimmunology 1988; 18: 75–86
   PubMedGoogle Scholar
• White S. R., Vyas D., Bieger D. Scrolonin immunorcaclivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis. Neuroseience 1985; 16: 701–709
   PubMedGoogle Scholar
• White S. R., Samathanam G. K., Bowker R. M., Wessendorf M. W. Damage to bulbospinal serotonin, tyrosine hydroxylase, and TRH-containing aims occurs early in the development of exprimental allergic encephalomyelitis in rats. Journal of Neuroseience Research 1990; 27: 89–98
   PubMedGoogle Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic eneephalomyelitis: An experimental model of multiple sclerosis. Annals of Neurology 1977; 1: 144–148
   PubMed Web of Science ®Google Scholar
• Zhitnukhin I. U. L., Zatepiakin I. U. S., Karasik O. A. Prevention of experimental allergic encephalomyelitis in guinea-pigs by treatment with magnetophores. Biull Eksp Biol Med 1995; 90: 713–715
   Google Scholar
• Zhon F. C., Azmitia F. C., Bledsoe S. Rapid serotonergic fiber sprouting in response to ibotenic acid lesion in the striatum and hippocampus. Brain Research and Developmental Brain Research 1980; 84: 89–98
   Google Scholar